Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

Alkaline phosphatase velocity in nonmetastatic CRPC

Nature Reviews Urology volume 11, pages 666–667 (2014)Cite this article

Subjects

Few prognostic factors have been identified and successfully replicated for patients with high-risk nonmetastatic castration-resistant prostate cancer (nmCRPC). However, a new report has shown that alkaline phosphatase velocity (APV) is an independent predictor of bone-metastasis-free survival and overall survival in patients with nmCRPC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Smith, M. R. et al. Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. Lancet 379, 39–46 (2012).

    Article  CAS  PubMed  Google Scholar 

  2. Smith, M. R. et al. Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer. J. Clin. Oncol. 23, 2918–2925 (2005).

    Article  PubMed  Google Scholar 

  3. Smith, M. R., Cook, R., Lee, K. A. & Nelson, J. B. Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration-resistant nonmetastatic prostate cancer. Cancer 117, 2077–2085 (2011).

    Article  PubMed  Google Scholar 

  4. Smith, M. R. et al. Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyses by baseline prostate-specific antigen doubling time. J. Clin. Oncol. 31, 3800–3806 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Saad, F. et al. CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 update. Can. Urol. Assoc. J. 7, 231–237 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Mohler, J. L. et al. Prostate Cancer, Version 2.2014. J. Natl Compr. Canc. Netw. 12, 686–718 (2014).

    Article  CAS  PubMed  Google Scholar 

  7. Metwalli, A. R. et al. Elevated alkaline phosphatase velocity strongly predicts overall survival and the risk of bone metastases in castrate-resistant prostate cancer. Urol. Oncol. http://dx.doi.org/10.1016/j.urolonc.2014.03.024 (2014).

  8. Ozu, C. et al. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer. Int. J. Urol. 15, 419–422 (2008).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, 200032, China

    Yao Zhu

  2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China

    Ding-Wei Ye

Authors
  1. Yao Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ding-Wei Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ding-Wei Ye.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, Y., Ye, DW. Alkaline phosphatase velocity in nonmetastatic CRPC. Nat Rev Urol 11, 666–667 (2014). https://doi.org/10.1038/nrurol.2014.192

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2014.192

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing